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Exposure to a compromised intra uterine environment has been known to alter fetal growth and 
metabolic processes with long term consequences for health. Maternal nutrition prior to and 
during gestation plays a role in fetal programming, however the mechanisms underlying these 
changes have not been fully elucidated.  This study was designed to evaluate the effects of 
fructose feeding on maternal serum and amniotic fluid insulin, corticotropin releasing hormone 
(CRH), C - reactive protein (CRP), and insulin-like growth factors (IGF-1 and IGF-2) on days 
12, 15 and 18 of pregnancy in control and fructose fed rats. Virgin female rats were randomly 
divided into 2 groups; control group fed with normal rat chow and fructose group fed with 
25% w/w fructose orally for 10 weeks. Female rats were mated with proven male rats and the 
presence of sperm cells in the virginal smear the following morning was taken as day 1 of 
pregnancy. Maternal serum and amniotic fluid samples were obtained on days 12, 15 and 18 of 
pregnancy for insulin, CRH, CRP, IGF-1 and   IGF-2 measurements using ELISA techniques. 
Maternal and amniotic fluid insulin, CRH, CRP and IGF-1 levels were significantly higher 
(p<0.05) in the fructose-fed group compared to the control group. IGF-2 level was not 
significantly different in the maternal and amniotic fluid samples in both groups. The results 
suggest that stress and inflammatory mechanisms may be implicated in the role maternal 
nutrition plays in developmental plasticity. 
  





A growing body of empirical evidence suggests that 
the origins of metabolic syndrome can be traced to 
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intrauterine life, when the developing fetus is acted 
upon by and responds to suboptimal conditions during 
critical periods of cellular proliferation, differentiation, 
and maturation by producing structural and functional 
changes in cells, tissues and organ systems. These 
changes, in turn, may have long-term consequences to 
increase the individual’s risk for developing metabolic 
disorders, which is the concept of fetal programming 
(Gluckman and Hanson, 2004).  
Fetal development is influenced by a complex factor 
of genetics, maternal nutrition, intra-uterine 
environment, maternal and fetal hormones. Exposure to 
a compromised intra-uterine environment has been 
known to alter fetal growth and metabolic processes 
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with long term consequences for health. Diabetic 
mothers have an additional influence of maternal 
hyperglycaemia, known to cause alterations in 
circulating maternal and fetal hormones, growth factors 
and cytokines. Maternal nutrition prior to and during 
gestation plays a role in fetal programming (Burdge 
and Lillycrop, 2010) and the mechanisms underlying 
these changes have not been well elucidated.  
CRH is a 41 amino acid peptide hormone first 
identified in the hypothalamus of mammals, where it 
acts as the main functional regulator of corticotrophin 
(ACTH) secretion from corticotropes of the anterior 
pituitary (Vale et al., 1981). Hypothalamic secretion of 
CRH is stimulated by many forms of physical or 
psychological duress and CRH plays a critical role in 
the coordination of neuroendocrine response to stress. 
Expression of the gene encoding for CRH has been 
recognized at a number of other sites, where it serves 
disparate roles. During pregnancy, the placenta and 
fetal membranes produce large amounts of CRH, 
although its function is not yet well understood. The 
synthesis of CRH in these tissues is known to increase 
as gestation advances. Some studies have indicated a 
role for placenta-derived CRH in the pathophysiology 
of diabetic pregnancies (Gangestad, Caldwell Hooper, 
and Eaton, 2012) and also in the onset of parturition 
(Ishimoto and Jaffe, 2011).  
CRH release from the hypothalamus is 
predominantly under neural control, however, the 
placenta has no nervous tissue, therefore placental CRH 
secretion is probably regulated exclusively by 
circulating and locally produced humoral factors. Some 
studies using either cultured placental trophoblasts or 
perifused placental villous tissue showed secretion of 
CRH in vitro (Grino, Chrousos, and Margioris, 1987; 
Saijonmaa, Laatikainen, and Wahlstrom, 1988) that can 
be stimulated by a number of neurotransmitters, 
cytokines, and polypeptide or steroid hormones. 
C-reactive protein (CRP) is a known inflammatory 
marker synthesized by the liver. It is a component of 
the immune system and one of the acute phase proteins 
released during systemic inflammation. An increase in 
serum levels of CRP has been reported to be an 
independent risk factor for cardiovascular disease 
(Ridker et al., 1998); insulin resistance (Frohlich et al., 
2000), and future development of type 2 diabetes 
mellitus (Pradhan et al., 2001). 
Type 2 diabetes mellitus has been associated with 
endothelial dysfunction and inflammation as well as 
increased production of cytokines by the adipose tissue 
(Balletshofer et al., 2000; Abderrahim-Ferkoune et al., 
2003). Experimental and epidemiologic studies have 
shown an association between increased levels of 
acute-phase proteins and pathologic conditions, such as 
type 2 diabetes mellitus, metabolic syndrome, obesity, 
and cardiovascular diseases (Pickup and Crook, 1998; 
Lagrand et al., 1999). Studies have also linked 
biomarkers such as CRP, plasminogen activator 
inhibitor-1, and interleukin -6 with type 2 diabetes 
mellitus in different populations (Pradhan et al., 2001; 
Festa et al., 2002).  
Insulin-like growth factors (IGFs) play a vital role 
during pregnancy by modulating fetal growth  
through their actions on the mother and placenta. 
Levels of circulating IGFs influence maternal 
metabolism thereby regulating nutrient availability for 
the fetus. Maternal IGFs also regulate placental 
morphogenesis, substrate transport and hormone 
secretion, all of which influence fetal growth either via 
indirect effects on maternal substrate availability, or 
through direct effects on the placenta and its capacity to 
supply nutrients to the fetus (Sferruzzi-Perri et al., 
2011). Altered fetal development is associated with 
increased perinatal morbidity and mortality and a 
greater risk of developing metabolic diseases in adult 
life, understanding the role of IGFs during pregnancy is 
essential to identify mechanisms underlying altered 
fetal programming. Perturbations in insulin-like growth 
factors have been implicated in diabetic pregnancies 
(Hiden et al., 2009). 
Fructose feeding induces insulin resistance and 
subsequently type 2 diabetes mellitus in rodents (Suga 
et al., 2000; Arikawe et al., 2006; Arikawe et al., 2008; 
Arikawe et al., 2012). We considered the potential role 
stress and inflammatory responses may play in diabetic 
pregnancies using corticotrophin releasing hormone 
(CRH), a stress marker produced by the placenta and C 
- reactive protein (CRP) an inflammatory response 
marker by evaluating the effect of fructose-induced 
insulin resistance on maternal serum and amniotic fluid 
insulin, CRH, CRP, IGF-1 and IGF-2 on days 12, 15 
and 18 of pregnancy in female rats.  
 
 
MATERIALS AND METHODS 
Animals  
Virgin female Sprague-Dawley rats aged 6 weeks, 
weighing 110 – 120 g were obtained from the 
laboratory animal department of the College of 
Medicine, University of Lagos. The animals were 
housed in clear polypropylene cages lined with wood 
chip beddings. Animals were kept under standard 
conditions of temperature 27ºC – 30ºC, with 12h 
light/dark cycle and were randomly divided into 2 
groups. Group 1 served as control group and was fed 
with normal rat chow. Group 2 served as the fructose 
group and was fed ad libitum on a special diet 
containing 25% fructose (SIGMA Aldrich, USA) 
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mixed with 75% normal rat chow weight/weight for 10 
weeks (Arikawe and Olatunji-Bello, 2004). At this 
fructose concentration, insulin resistance state was 
100% with zero mortality rate. Body weight and blood 
glucose levels were measured at the beginning of the 
experiment and weekly from the tail vein of the rats in 
both groups using Dextrostix Test Strips (Bayer 
Corporation, U. K.) after an overnight fast till diabetes 
mellitus was induced in group 2 rats. Hyperglycaemia 
was confirmed using the glucose oxidase method 
(Hugget and Nixon, 1957). All animals had free access 
to drinking water throughout the duration of the study. 
The procedures were performed in accordance with 
guidelines of the College Ethical Committee on the use 
of laboratory animals for research. 
 
Vaginal smears and Induction of pregnancy  
The stage of cyclicity in the two groups was 
determined by microscopic analysis of the predominant 
cell type in vaginal smears obtained daily from the 8th 
week (Marcondes, Bianchi, and Tanni,  2002) till the 
10th week of feeding i.e. a two-week period. Only 
female rats showing two consecutive estrous cycles of 
the same length were used (Cruz, et al., 1990). 
Pregnancy was induced at the end of the 10th week by 
mating at night a pro-estrous female rat with mature 
and proven adult male rat. This was to ensure that 
copulation occurred at estrus, the only time the female 
rat is receptive to the male rat. Successful mating was 
confirmed by the presence of sperm cells in the vaginal 
smear, and was regarded as day 1 of pregnancy. 
Animals were further divided into 3 subgroups namely 
Day 12, 15 and 18 for both groups. 
 
Sample collection and assays of parameters  
Cervical dislocation was carried out on the animals in 
the two groups on days 12, 15 and 18 of pregnancy. 
Summarily, the animals were placed supine on the 
dissecting board following dislocation of the spine at 
the cervical region. With a pair of forceps and scissors, 
the lower abdominal region was cut open. This incision 
was extended upwards into the upper abdominal region 
and subsequently into the thoracic region, to expose the 
contents of the abdomen and the thorax. Blood was 
quickly collected by cardiac puncture into plain sample 
bottles and allowed to clot. Blood samples were 
centrifuged at 3,000 rpm for 15 minutes to get clear 
serum samples, which were subsequently kept frozen (-
20ºC). Laparatomy was done and the gravid uterus 
exposed, clear amniotic fluid was obtained from the 
gestational sacs using a 28G needle and 1ml syringe. 
Maternal serum and amniotic fluid samples were 
obtained on different days of pregnancy namely days 
12, 15 and 18 to assess the trend of insulin, CRH, CRP, 
IGF-1and IGF-2 levels as pregnancy advanced. 
  
Analysis of parameters 
Maternal serum and amniotic fluid samples were 
analyzed for insulin, CRH, CRP, IGF-1 and IGF-2 
using ELISA technique. Insulin was analyzed using 
Diagnostic Automation Inc. USA kit with minimum 
detection limit of 0.03 IU/L, IGF-1 and IGF-2 were 
measured using DSL kit; Diagnostics Systems 
Laboratories, TX. Maternal plasma and amniotic fluid 
CRP and CRH concentrations were measured using 
DRG kits, USA. The intra- assay coefficient of 
variation for CRP was 7.5% and the inter assay 
coefficient of variation for CRP was 4.1%. 
 
Assessment of placental and fetal parameters 
On day 18 of pregnancy in both groups, laparatomy 
was done to expose the uterus and assess the fetus and 
the placenta tissue. The gestational sacs was carefully 
opened after amniotic fluid has been collected using a 
23G needle and 1ml syringe, placental weight, fetal 
weight, cord length, litter size and number of resorption 
sites. The placentae and fetuses were isolated carefully 
with the aid of forceps without cutting the umbilical 
cord; the length of the cord was measured using thread 
from the umbilicus to the point of attachment on the 
placenta, marked and the length read from a graduated 
ruler. The number of resorption site was determined by 
counting the number of implantation sites in the uterus 
that failed to develop. 
Statistical analysis 
Results are expressed as means ± S.E.M. The 
significance of differences among groups was analyzed 
statistically using Student’s unpaired t – test. 
Differences were considered statistically significant at 
P < 0.05. 
 
RESULTS 
Fasting blood glucose concentration (mg/dl) at the 
beginning of the experiment, 2nd, and 4th week in 
Control rats was (78.5 ± 6.3, 80.8 ± 5.4, 82.2 ± 4.6 
mg/dl) and in fructose-fed rats was (79.8 ± 5.5, 82.4 ± 
3.4, 98.6 ± 3.0 mg/dl). Fasting blood glucose at the 6th, 
8th, and 10th week in Control rats was (84.6 ± 6.5, 85.8 
± 3.2, 86.0 ± 6.4 mg/dl) and in fructose-fed rats was 
(120.6 ± 6.8, 128.9 ± 4.6, 142.6 ± 5.8 mg/dl) 
respectively. There was no significant difference in 
fasting blood glucose concentration in the 2 groups at 
the beginning of the experiment till the 4th week (Table 
1).  However, blood glucose level was significantly 
higher in the fructose-fed rats from the 4th week till the 
10th week and this was confirmed by hyperglycemia 
following an overnight fast.  
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Table 1. Fasting blood glucose (mg/dl) concentration in 
Control and Fructose-fed 




Week 0 78.0 ± 6.3 79.8 ± 5.5 
Week 2 80.8 ± 5.4 82.4 ± 4.4 
Week 4 75.2 ± 4.2 98.6 ± 3.0* 
Week 6 75.8 ± 6.5 120.6 ± 6.8* 
Week 8 76.0 ± 3.2 124.9 ± 4.6* 
Week 10 82.0 ± 6.0 142.6 ± 5.8* 
Data are expressed as mean ± SEM (n = 30) * p<0.05 Vs Control 
 
Body weight (gm) at the beginning of the experiment, 
2nd, and 4th week in Control rats was (90.0 ± 1.1gm, 
94.8 ± 1.9 gm, 105.2 ± 1.6 gm) and fructose –fed rats 
was (95.0 ± 1.2 gm, 109.0 ± 1.3 gm, 115.8 ± 1.0 gm).  
Body weight (gm) at the 6th, 8th, and 10th week in 
Control rats was (112.8 ± 1.5gm, 123.3 ± 1.5 gm, 134.0 
± 1.4 gm) and fructose-fed rats was (109.8 ± 1.0 gm, 
103.8 ± 1.1 gm, 95.2 ± 0.9 gm) respectively. There was 
no significant difference in body weight amongst the 
two groups at the beginning of the experiment till the 
6th week. However, body weight began to significantly 
decline (P < 0.05) in the fructose-fed group when 
compared to the control group from the 6th week till the 
end of experiment (Table 2). 
 
Table 2. Body weight (gm) in Control and Fructose-fed rats 
 Control Fructose-fed 
Week 0 110.5 ± 1.1 111.0 ± 1.3 
Week 2 118.4 ± 1.9 119.5 ± 1.6 
Week 4 126.2 ± 1.6 117.7 ± 1.5 
Week 6 132.8 ± 1.2 90.8  ± 1.9* 
Week 8 137.3 ± 1.8 80.5 ± 1.7* 
Week 10 142.0 ± 1.6 67.7 ± 2.1* 
Data are expressed as mean ± SEM (n = 30) * p<0.05 Vs 
Control 
 
Maternal serum and amniotic fluid insulin was 
significantly higher (p<0.05) in the fructose-fed group 
compared to the control during pregnancy. There was 
however a progressive increase in maternal insulin 
levels as pregnancy advanced in both groups but insulin 
levels in the fructose-fed rats were over 2 folds that of 
the control rats (Table 3). IGF-1 levels in maternal 
serum and amniotic fluid of fructose-fed rats were 
increased significantly compared to the control and this 
also increased as pregnancy advanced (Table 4) while 
IGF-2 levels were not significantly different in the 
maternal serum and amniotic fluid of both groups 
(Table 5). 
 
Table 3. Insulin concentrations (IU/L) in maternal serum and 











21 ± 1.2 24 ± 0.8 27 ± 0.7 
Maternal serum 
Fructose-fed 
38 ± 2.1† 44 ± 2.3† 54 ± 2.1† 
Amniotic fluid 
Control 
2.1 ± 0.1 2.8 ± 0.1 3.1 ± 0.2 
Amniotic fluid 
Fructose-fed 
6.3 ± 0.6* 7.2 ± 0..4* 8.8 ± 0.2* 
Data are expressed as mean ± SEM † P<0.001 Vs. Control 
(Maternal serum); *P<0.05 Vs. Control (Amniotic fluid) 
 
Placental weight increased significantly (p<0.05) in the 
fructose-fed group (0.40±0.08gm) compared to the 
control group (0.28 ± 0.03gm) on day 18 of pregnancy, 
placental diameter was also significantly increased in  
 
 
Table 4. IGF-1 (pg/ml) concentrations in maternal serum and 
amniotic fluid of Control and Fructose-fed pregnant rats. 








0.99 ± 0.14 1.24±0.21 1.67±0.22 
Maternal serum 
Fructose-fed 
2.21±0.10† 3.66±0.30† 4.61±0.10† 
Amniotic fluid 
Control 
0.21±0.06 0.33±0.03 0.39±0.02 
Amniotic fluid 
Fructose-fed 
0.63±0.05* 0.98±0.04* 1.02±0.02* 
Data are expressed as mean ± SEM  † P<0.001 Vs. Control 
(Maternal serum); *P<0.05 Vs. Control (Amniotic fluid) 
 
the fructose-fed group (1.64 ± 0.44cm) compared to the 
control group (0.82 ± 0.26cm). There was a significant 
decrease in fetal weight on day 18 of pregnancy in the 
fructose-fed group (2.2 ± 0.49gm) compared to the 
control (3.9 ± 0.38gm). Litter size, cord length and 
number of resorption sites were however not 
significantly different in both groups (Table 6).  
Maternal serum and amniotic fluid CRH levels were 
significantly higher (p<0.05) in the fructose-fed group 
compared with the control group. Maternal and 
amniotic fluid CRH levels increased progressively as 
pregnancy advanced in both groups. However, CRH 
levels in maternal and amniotic fluid of the fructose-fed 
group were significantly higher (p<0.001) compared to 
the control group (Table 7).  
CRP levels were significantly (p<0.05) increased in 
the maternal serum of fructose-fed group on days 12, 
CRH, C-reactive protein in pregnant insulin-resistant rats 
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15 and 18 of pregnancy compared to the control group. 
There was however no significant difference in 
maternal serum CRP levels in the control and fructose-
fed groups as pregnancy advanced. A significant 
progressive increase in amniotic fluid CRP was 
observed in the fructose-fed group with no significant 
(p=0.15) corresponding increase in maternal serum 




Fructose feeding through insulin resistance 
mechanism induces Type 2 diabetes mellitus in female 
rats, evident by hyperglycemia, hyperinsulinemia and 
body weight loss observed in the present study. This 
finding is in line with the view of Suga et al., 2000. The 
result also indicates that pregnancy is a diabetogenic 
state (Vannini, 1994).  
 
Table 5. IGF-2 concentrations (x104 pg/ml) in maternal 
serum and amniotic fluid of control and fructose-fed 
pregnant rats.  






















Data are expressed as mean ± SEM  
 
Body weight increased progressively in both groups 
as anticipated until the 4th week, when it became 
significantly higher in the fructose-fed group compared 
to control group. It then declined in the fructose group 
till the 10th week when it became significantly lower 
compared to the control group.  The body weight 
pattern in this study is in line with our earlier 
observations (Arikawe et al., 2006; Arikawe et al., 
2008; Arikawe et al., 2012) that body weight in insulin 
resistant diabetic rats begins to decline from the 4th 
week. This decline is suggested to be due to the onset 
of diabetes in rats in the fructose-fed group, which is 
characterized by gluconeogenesis leading to muscle 
waiting and weight loss. Our result on body weight is 
also in line with the view of Catena et al., (2003), who 
reported that fructose feeding has no significant effect 
on body weight of virgin female rats in the first two 
weeks of feeding.  
Serum insulin level is a crucial factor to control 
normal blood glucose level (Islam and Choi, 2008). It 
was as expected significantly higher in fructose-fed 
group compared to the control group. Chronic fructose 
consumption caused structural alterations in pancreatic 
β cells (Lee at al., 2010; Van Assche, Aerts, and de 
Prins, 1983) to cause hyperinsulinaemia. During 
pregnancy, maternal serum and amniotic fluid insulin 
levels increased progressively as pregnancy advanced 
in both groups, an indication of pregnancy-induced 
insulin resistance; however insulin levels in the 
fructose-fed rats were over two folds the control rats in 
which the physiological insulin resistance of pregnancy 
was observed. A similar result was reported by Saito et 
al., 2010. Amniotic fluid insulin is of fetal origin, since 
maternal insulin cannot cross the placental barrier 
(Dickinson and Palmer, 1990). Fetal insulin is excreted 
via fetal urine into the amniotic fluid, and this has been 
reported to increase as fetal insulin production 
increases (Illsley, 2000). Increased amniotic fluid 
insulin has been associated with fetal morbidity or 
mortality (Buchanan and Coustan, 1994) and 
macrosomia (Jansen, Greenspoon, and Palmer, 2003). 
 
Table 6. Placental and fetal parameters in Control and 
Fructose-fed pregnant rats on day 18 of pregnancy 
Parameters Control Fructose-fed 
Placental weight (gm) 0.28 ± 0.03 0.40 ± 0.08*  
Placental diameter (cm) 
0.82 ± 0.26 1.64 ± 0.44*  
Fetal weight (gm) 3.9 ± 0.38 2.2 ± 0.49*   
Fetal/Placenta weight  
13.9 ± 3.65 5.5 ± 1.24* 
Cord Length (cm) 1.44 ± 0.28  1.68 ± 0.34  
Litter size (n) 7.3 ± 2.1 6.2 ± 1.4 
Resorption sites (n) 
2.82 ± 0.06 3.24 ± 0.49 
Data are expressed as mean ± SEM (n = 10) * p<0.05 Vs 
Control 
 
Maternal serum and amniotic fluid IGF- 1 and IGF- 
2 of the fructose fed pregnant rats are consistent with 
the findings of Fowden (2003). Serum and amniotic 
fluid IGF-1 levels were significantly higher in the 
fructose group compared to the control, while there was 
no significant difference in maternal and amniotic fluid 
IGF-2 levels, although a progressive increase was 
observed as pregnancy advanced in both groups. This is 
in line with the view of Sferruzzi-Perri et al. (2011). 
IGF-1 is reported to have mitogenic actions including 
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stimulation of cellular growth, proliferation and 
differentiation (Sara and Hall, 1990), enhancement of 
glucose and amino acid uptake (Turkalj, Keller, and 
Ninnis, 1992) and appears to be the dominant growth 
promoting factor during the rapid phase of somatic 
growth in late gestation (Baker et al., 1993).  
 
Table 7. Maternal serum and amniotic fluid CRH (pg/ml) 
concentrations in control and fructose-fed pregnant rats.    
 








34.1 ± 3.2 42.6±2.9 50.8±2.2 
Maternal serum 
Fructose-fed 
42.3±2.8† 58.4±3.0† 76.8±2.6† 
Amniotic fluid 
Control 
2.6±0.14 3.8±0.16 6.5±0.52 
Amniotic fluid 
Fructose-fed 
8.3±0.25* 15.4±0.84* 21.9±0.86* 
Data are expressed as mean ± SEM † P<0.001 Vs. Control 
(Maternal serum); *P<0.05 Vs. Control (Amniotic fluid) 
 
 
Table 8. Maternal and amniotic fluid CRP (mg/dl) 
concentrations in Control and Fructose-fed pregnant rats.    








0.25 ± 0.08 0.32±0.11 0.38±0.12 
Maternal serum 
Fructose-fed 
3.2±0.10† 3.7±0.17† 4.1±0.19† 
Amniotic fluid 
Control 
0.11±0.03 0.15±0.06 0.16±0.04 
Amniotic fluid 
Fructose-fed 
0.44±0.05* 0.78±0.04* 1.23±0.08* 
Data are expressed as mean ± SEM † P<0.001 Vs. Control 
(Maternal serum); *P<0.05 Vs. Control (Amniotic fluid) 
 
 
Furthermore, maternal serum and amniotic fluid 
CRH levels were significantly higher in fructose- fed 
rats compared to the control; there was however a 
progressive increase of maternal and amniotic fluid 
CRH in both groups as pregnancy advanced. This 
suggests that chronic fructose feeding leading to 
hyperglycemia and hyperinsulinemia could induce both 
maternal and fetal distress during pregnancy. 
Intrauterine exposure to stress may interact with the 
altered nutritional milieu which may represent an 
underlying mechanism mediating the effects of 
intrauterine malprogramming. Wadhwa, 2005; 
Entringer et al., 2012 also support this view from their 
findings.  
From the findings of this study, maternal serum and 
amniotic fluid CRP levels were significantly higher  in 
the fructose-fed pregnant rats compared to the control, 
and increased  amniotic fluid CRP levels was observed 
as pregnancy advanced with no significant 
corresponding increase in maternal serum CRP levels. 
Since an increase in this marker has been shown to be 
an indication of cellular inflammation, it may suggest 
that chronic fructose feeding could lead to the 
activation of inflammatory cascade during pregnancy in 
rats. This finding is consistent with reports of Rota et 
al., (2005) who reported higher CRP levels in patients 
with gestational diabetes. Edalat et al., (2013) also 
reported a similar finding in women with previous 
gestational diabetes mellitus and metabolic syndrome. 
Retnakaran et al., (2003) who measured CRP at various 
gestational ages in pregnant women however found 
inconsistent results regarding the association between 
inflammatory markers and type 2 diabetes mellitus. The 
interpretation of the results was influenced by 
coexistence of hypertension, preeclampsia, and 
different racial groups or small sample size in some 
studies. Inconsistent results regarding the association 
between inflammatory markers and diabetic 
pregnancies are related to different racial groups or 
small sample size and different methods of researches.  
The reduction in fetal weight recorded in the 
fructose-fed rats may suggest intra uterine growth 
restriction, which may be attributed to the over 
insulinisation and poor maternal glycemic control, as 
also reported by Parikh et al., (2007). Increased 
placental weight and diameter observed in the fructose 
group may be a placental adaptation to the increased 
influx of glucose from maternal compartment to the 
fetus, as reported by Vitoratos, Vrachnis, and 
Valsamakis, (2010) in the placenta of gestational 
diabetic women. The weight of the placenta has been 
used to assess its functions and fetal development. A 
correlation between placental weight, maternal 
diabetes, preeclampsia, birth weight and fetal distress 
has been reported in humans (Hindmarsh et al., 2000). 
Increase in placental size and low birth weight has been 
indicated as a risk factor for developing metabolic 
diseases in adulthood (Lo et al., 2002). Placental 
hypertrophy have also been postulated as an adaptation 
to maintain placental function in diabetic pregnancies, 
resulting in small for gestational age neonates with 
increased placental to birth weight ratio when 
compared to non-diabetic pregnancies with appropriate 
for gestational age neonates (Asgharnia et al., 2008). 
In conclusion, the study shows that stress and 
inflammatory mechanisms may be implicated in the 
role maternal nutrition plays in developmental 
plasticity as indicated by elevated CRH and CRP levels 
observed in the fructose-induced diabetic pregnant rats. 
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